Phono-Motor Therapy + Semantic Feature Analysis for Dyslexia
(AMT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two types of therapy to determine which better aids reading difficulties caused by a stroke. Participants will receive either phono-motor therapy, which focuses on sounds and speech movements, or semantic feature analysis, which emphasizes understanding word meanings. The goal is to determine if matching the therapy to a person's specific type of reading impairment proves more effective. This trial suits those who had a stroke and now struggle with reading, provided they were fluent in English before the stroke and can still see and hear well. Participants will follow a thorough treatment schedule, with therapy sessions spread over several weeks. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could tailor therapies to individual needs.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Phono-Motor Therapy (PMT) is generally well-tolerated. One study found it improves the use of sounds in language and enhances oral reading skills. No serious side effects were reported, suggesting safety for individuals with reading difficulties.
Semantic Feature Analysis (SFA) is also considered safe. Studies have demonstrated that it improves vocabulary and reading comprehension without major side effects. It has been successfully used with both children and adults.
Both treatments have shown positive results in past studies, indicating they are safe and could benefit individuals with dyslexia. Participants typically handle these therapies well.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it combines Phono-Motor Therapy and Semantic Feature Analysis in a way that is tailored to each individual's specific type of dyslexia. Unlike standard treatments that often use a one-size-fits-all approach, this trial uses computational modeling to predict the most effective therapy for each person's unique reading challenges. This personalized approach could lead to more effective and faster improvements in reading skills, making it a promising avenue for individuals with acquired dyslexia. By focusing on both phonological and semantic aspects of language processing, the trial aims to address the root causes of reading impairments more comprehensively than existing therapies.
What evidence suggests that this trial's treatments could be effective for dyslexia?
Research shows that phono-motor therapy (PMT) can enhance sound processing and reading aloud. Some studies suggest PMT might outperform other methods for those with language difficulties. However, not everyone experiences improved reading comprehension, though some individuals do benefit. In this trial, participants in the model-matched group may receive PMT if it aligns with their computational model prediction.
Semantic Feature Analysis (SFA) has successfully helped individuals with language impairments improve their ability to name objects and ideas. Studies consistently show positive results, indicating that SFA can enhance naming skills. Participants in the model-matched group may receive SFA if it matches their computational model prediction. Both therapies target different areas but have shown promise in addressing specific language challenges.13678Who Is on the Research Team?
William W Graves, PhD
Principal Investigator
Rutgers, The State University of New Jersey
Are You a Good Fit for This Trial?
This trial is for individuals who have developed dyslexia following a stroke. Participants should be willing to undergo two full rounds of cognitive therapy treatments, each lasting 60 hours over several weeks.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment Round 1
Participants receive either phonomotor treatment (PMT) or semantic feature analysis (SFA) for 60 hours, distributed over 5 days a week for 2 hours a day
Treatment Round 2
Participants receive the alternative therapy for another 60 hours, distributed over 5 days a week for 2 hours a day
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Acquired Dyslexia Modeling and Treatment
- Phono-Motor Therapy
- Semantic Feature Analysis
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rutgers, The State University of New Jersey
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator